Company: NDRA
Filing Date: 2025-10-30
Form Type: 424B5
Source: 0001213900-25-103705
Chunk: 73

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-10-30
Form: 424B5
Chunk 73
---
 a part. Our financial statements
are incorporated by reference in reliance on RBSM LLP’s report, given on their authority as experts in accounting and auditing.

<div align='center'>WHERE YOU CAN FIND
MORE INFORMATION</div>

We file annual, quarterly and special reports,
proxy statements and other information with the Securities and Exchange Commission (the “SEC”). You can inspect and copy these
reports, proxy statements and other information at the SEC’s Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549.
Please call the SEC at 1-800-SEC-0330 for further information on the Public Reference Room. The SEC also maintains a web site that contains
reports, proxy and information statements and other information regarding issuers, such as ENDRA Life Sciences Inc. (www.sec.gov). Our
web site is located at www.endrainc.com. The information contained on, or that may be obtained from, our website is not, and shall not
be deemed to be, a part of this prospectus.

We will provide, upon written or oral request,
without charge to you, including any beneficial owner to whom this prospectus is delivered, a copy of any or all of the documents incorporated
herein by reference other than the exhibits to those documents, unless the exhibits are specifically incorporated by reference into the
information that this prospectus incorporates. You should direct a request for copies to ENDRA Life Sciences Inc., 3600 Green Court, Suite
350, Ann Arbor, Michigan 48105; Telephone: (734) 335-0468.

<div align='center'>25

INCORPORATION BY
REFERENCE</div>

The SEC allows us to “incorporate by reference”
information from other documents that we file with it, which means that we can disclose important information to you by referring you
to those documents. The information incorporated by reference is considered to be part of this prospectus. Information in this prospectus
supersedes information incorporated by reference that we filed with the SEC prior to the date of this prospectus.

We incorporate by reference into this prospectus
and the registration statement of which this prospectus is a part the information or documents listed below that we have filed with the
SEC:

| ● | The description of the Company’s common stock contained in the Company’s Registration Statement on Form 8-A                                   
 (File No. 001-37969) initially filed with the SEC on December 16, 2016 pursuant